Ultrasound Molecular Imaging With VEGFR2 ‐Targeted Microbubbles to Evaluate Intrauterine Adhesion After Endometrial Injury and Monitor the Therapeutic Effects
Journal of Ultrasound in Medicine · 2025
DOI: 10.1002/jum.16710 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ultrasound in Medicine, 2025. Verfasst von Likang Hou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medical Imaging Precision Theranostics and Radiation Protection, College of Hunan Province, the Affiliated Changsha Central Hospita…. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor Receptor-2, Microbubbles, Contrast Media, Molecular Imaging. Die Arbeit nennt 25 Literaturangaben. Gefördert von: Clinical Research 4310 Program of the Affiliated Changsha Central Hospital of the University of South China, Health Research Project of Hunan Provincial Health Commission, National Natural Science Foundation of China.
Abstract (Originalsprache)
Objectives
To assess the severity of intrauterine adhesion (IUA) after endometrial injury via ultrasound molecular imaging (USMI) of vascular endothelial growth factor receptor 2 (VEGFR2) expression on the uterine endothelium.
Methods
MB VEGFR2 was constructed via “biotin‐avidin‐biotin” bridging technology. A rat IUA animal model was constructed via chemical injury. Fourteen days after the model was constructed, MB Con and MB VEGFR2 contrast agents were injected into the standard group and the model group of rats, and simultaneous ultrasound molecular imaging was carried out and ultrasound molecular imaging was performed and the changes in ultrasound signals in vivo were normalized to differential targeted enhancement (dTE). In addition, immunohistochemistry was used to detect the expression levels of VEGFR2 and α‐SMA in the uterine tissues of the rats in both groups.
Results
Targeted‐VEGFR2 microbubble (MB VEGFR2 ) was successfully constructed, the average particle size of the targeted VEGFR2 microbubble contrast agent was 2309.6 ± 234.3 nm, with the average zeta potential ‐16.9 ± 0.15 mV and the dispersity coefficient less than 0.4. In addition, its essential performance and biosafety were examined, which revealed that the MB VEGFR2 contrast agent had an appropriate size, stable imaging performance, good target adhesion, and good biocompatibility. In vivo, ultrasound imaging results revealed that after the injection of the targeted MB VEGFR2 , the contrast ultrasound signal intensity of uterine tissues in the model group (62.5 ± 17.9 dB) was higher than in the normal group (33.5 ± 12.5 dB), and the difference was statistically significant ( P < .05). The immunohistochemistry results revealed that the expression of VEGFR2 and α‐SMA in the uterine tissue of the model group was greater than that in the standard group ( P < .05), further indicating that the signal intensity of the MB VEGFR2 contrast agent can reflect the expression level of VEGFR2 molecules.
Conclusions
Ultrasound molecular imaging based on MB VEGFR2 can be used to evaluate the expression level of VEGFR2 in uterine vascular endothelial cells. This provides a potential approach for the early diagnosis and treatment monitoring of intrauterine adhesions after endometrial injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Medical Imaging Precision Theranostics and Radiation Protection, College of Hunan Province, the Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, China.
- Institute of Medical Imaging, Hengyang Medical School, University of South China, Hengyang, China.
- Department of Ultrasound Medicine, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
- Department of Medical Imaging, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, China.
ORCID-Profile: Zhiyi Chen
Förderung
- Clinical Research 4310 Program of the Affiliated Changsha Central Hospital of the University of South China
- Health Research Project of Hunan Provincial Health Commission
- National Natural Science Foundation of China
Zitieren
APA
Hou, L., Guo, Z., Liu, S., Liang, X., Du, M., & Chen, Z. (2025). Ultrasound Molecular Imaging With VEGFR2 ‐Targeted Microbubbles to Evaluate Intrauterine Adhesion After Endometrial Injury and Monitor the Therapeutic Effects. Journal of Ultrasound in Medicine. https://doi.org/10.1002/jum.16710
Vancouver
Hou L, Guo Z, Liu S, Liang X, Du M, Chen Z. Ultrasound Molecular Imaging With VEGFR2 ‐Targeted Microbubbles to Evaluate Intrauterine Adhesion After Endometrial Injury and Monitor the Therapeutic Effects. Journal of Ultrasound in Medicine. 2025. doi:10.1002/jum.16710
BibTeX
@article{Hou2025,
author = {Hou, Likang and Guo, Zhili and Liu, Shun and Liang, Xiaowen and Du, Meng and Chen, Zhiyi},
title = {Ultrasound Molecular Imaging With VEGFR2 ‐Targeted Microbubbles to Evaluate Intrauterine Adhesion After Endometrial Injury and Monitor the Therapeutic Effects},
journal = {Journal of Ultrasound in Medicine},
year = {2025},
doi = {10.1002/jum.16710}
}
EUVIMED